BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE: Research Article: Metabolic Dysregulation and Psychopathology
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metabolic syndrome components-waist circumference, high-density lipoprotein cholesterol (HDL-C), triglycerides, systolic blood pressure and fasting glucose-are cross-sectionally associated with depression and anxiety with differing strength. Few studies examine the relationships over time or whether antidepressants have independent effects. METHODS: Participants were from the Netherlands Study of Depression and Anxiety (NESDA; N = 2,776; 18-65 years; 66% female). At baseline, 2- and 6-year follow-up, participants completed diagnostic interviews, depression and anxiety symptom inventories, antidepressant use assessment, and measurements of the five metabolic syndrome components. Data were analyzed for the consistency of associations between psychopathology indicators and metabolic syndrome components across the three assessment waves, and whether psychopathology or antidepressant use at one assessment predicts metabolic dysregulation at the next and vice versa. RESULTS: Consistently across waves, psychopathology was associated with generally poorer values of metabolic syndrome components, particularly waist circumference and triglycerides. Stronger associations were observed for psychopathology symptom severity than diagnosis. Antidepressant use was independently associated with higher waist circumference, triglycerides and number of metabolic syndrome abnormalities, and lower HDL-C. Symptom severity and antidepressant use were associated with subsequently increased number of abnormalities, waist circumference, and glucose after 2 but not 4 years. Conversely, there was little evidence that metabolic syndrome components were associated with subsequent psychopathology outcomes. CONCLUSIONS: Symptom severity and antidepressant use were independently associated with metabolic dysregulation consistently over time and also had negative consequences for short-term metabolic health. This is of concern given the chronicity of depression and anxiety and prevalence of antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322 · cited 1×
“than overweight and depression.[62, 63] It may also be partly due to the sample composition, which at baseline largely consisted of people with high psychopathology symptoms who decrease in their symptoms over time as a consequence of treatment or naturalistic change.”
BackgroundSelf-citationThe Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 6×
“Higher IDS score at baseline were weakly associated with lower HDL-C by 2-year follow-up.”
MethodInfluentialBrief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801 · cited 1×
“severity of psychopathology symptoms: the 30-item inventory of depressive symptomatology (IDS)[30,31] for depressive symptoms, the 21item Beck Anxiety Inventory (BAI)[32] for measuring the psychological and arousal components of anxiety, and the 24-item fear questionnaire (FQ)[33] for measuring fear avoidance symptoms.”
MethodPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Self-citationBidirectional Association Between Depression and Metabolic Syndrome
Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012) · Diabetes Care · doi:10.2337/dc11-2055 · Cited by 772
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Meng, L., Chen, D., Yang, Y., Zheng, Y., & Hui, R. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835080b7 · Cited by 526 · cited 1×
“Although a relationship between depression and hypertension is often observed,[39, 40] a negative association between psychopathology and SBP has been reported previously in NESDA and other cohorts.”
ResultLicht, C. M. M., de Geus, E. J. C., Seldenrijk, A., van Hout, H. P. J., Zitman, F. G., van Dyck, R., & Penninx, B. W. J. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126698 · Cited by 319
Self-citationVancampfort, D., Correll, C. U., Wampers, M., Sienaert, P., Mitchell, A. J., De Herdt, A., Probst, M., Scheewe, T. W., & De Hert, M. (2014) · Psychological Medicine · doi:10.1017/s0033291713002778 · Cited by 317
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
Licht, C. M. M., Vreeburg, S. A., van Reedt Dortland, A. K. B., Giltay, E. J., Hoogendijk, W. J. G., DeRijk, R. H., Vogelzangs, N., Zitman, F. G., de Geus, E. J. C., & Penninx, B. W. J. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2801 · Cited by 240
Self-citationGoldbacher, E. M., & Matthews, K. A. (2007) · Annals of Behavioral Medicine · doi:10.1007/bf02874549 · Cited by 196
Van Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
Self-citationPatten, S. B., Williams, J. V. A., Lavorato, D. H., Campbell, N. R. C., Eliasziw, M., & Campbell, T. S. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181988e5f · Cited by 152 · cited 1×
“Although a relationship between depression and hypertension is often observed,[39, 40] a negative association between psychopathology and SBP has been reported previously in NESDA and other cohorts.”
ResultBeyazyüz, M., Albayrak, Y., Eğilmez, O. B., Albayrak, N., & Beyazyüz, E. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.2.148 · Cited by 83 · cited 2×
“[24–26] For instance, SSRI use has been associated with weight gain, loss and no change, as well as both impaired and improved glucose and lipid profiles.[23, 26] SSRI use is also associated with positive impacts on biological correlates of metabolic dysregulation, such as inflammation,[27, 28] which may in part expla…”
BackgroundFontana, L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.005 · Cited by 81
The impact of statins on psychological wellbeing: a systematic review and meta-analysis
O'Neil, A., Sanna, L., Redlich, C., Sanderson, K., Jacka, F., Williams, L. J., Pasco, J. A., & Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-154 · Cited by 78
Siennicki-Lantz, A., André-Petersson, L., & Elmståhl, S. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.11.007 · Cited by 16
Cited by
Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566
Self-citationSlyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278
Tang, F., Wang, G., & Lian, Y. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.025 · Cited by 117
Vancampfort, D., Koyanagi, A., Hallgren, M., Probst, M., & Stubbs, B. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.11.002 · Cited by 108
“However, a number of hypotheses have been proposed for the increased risk of physical conditions in people with anxiety including psychotropic medication use [40], biological risk factors such as an increased inflammatory profile, including increased levels of C-reactive protein and interleukin-6 [41] and”
Background
Metadata
- Authors
- Hiles, S. A., Révész, D., Lamers, F., Giltay, E., & Penninx, B. W. J. H.
- Venue
- Depression and Anxiety
- Publisher
- Wiley
- Published
- 2016-04-27
- Volume
- 33
- Issue
- 8
- Pages
- 754-764
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2344698282
- Cited by
- 103
- References
- 21
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.